DACH Pharmacy Digital Retail: Market Statistics and Projections to 2026

The digital transformation within the DACH pharmacy sector continues to evolve, driven by regulatory shifts, technological advancements, and changing consumer purchasing behaviors. This analysis presents key market statistics and projections for digital retail in pharmacies across Germany, Austria, and Switzerland, offering a data-centric overview of this dynamic segment.

DACH Digital Pharmacy Market Size and Growth Trajectory

The aggregated digital pharmacy retail market across the DACH region, encompassing both Over-The-Counter (OTC) products and prescription medications (Rx), demonstrates a consistent growth trajectory. Germany represents the predominant share of this market due to its larger population and established regulatory framework for online pharmacies (Versandapotheken). Austria and Switzerland, while smaller in absolute terms, also contribute to the regional expansion of digital pharmacy channels.

In 2023, the total digital pharmacy market in the DACH region reached an estimated value of €6.8 billion. Projections indicate a Compound Annual Growth Rate (CAGR) of 11.5% for the period spanning 2023 to 2026, leading to an anticipated market volume of €9.5 billion by 2026. This growth is primarily fueled by increasing consumer acceptance of online purchasing for health products and the ongoing digitalization of prescription processes.

The online share of the total pharmacy market in the DACH region was approximately 8.2% in 2023. This share is projected to expand to 11.5% by 2026. This expansion reflects a gradual shift from traditional brick-and-mortar pharmacies towards digital channels, though physical pharmacies retain a significant majority of transactions.

Note: Germany’s market share calculation is based on revenue contribution within the DACH digital pharmacy segment.

Segmented Market Performance: OTC vs. Rx Digital Retail

The DACH digital pharmacy market is segmented into Over-The-Counter (OTC) and prescription (Rx) medication sales, each operating under distinct regulatory frameworks and exhibiting differing growth dynamics.

Over-The-Counter (OTC) Digital Retail

The OTC segment constitutes the larger portion of digital pharmacy sales in the DACH region. Consumers routinely purchase non-prescription drugs, health supplements, and personal care products online. In 2023, OTC products accounted for approximately 78% of the total digital pharmacy market revenue. This segment is characterized by consumer convenience, competitive pricing structures, and a broad product assortment. The projected CAGR for OTC digital sales across DACH from 2023 to 2026 stands at 8.5%, indicating continued, steady expansion.

Prescription (Rx) Digital Retail

The Rx segment’s growth in digital channels is intrinsically linked to regulatory developments, particularly in Germany. Historically, the mail-order ban for prescription drugs (Versandhandelsverbot für verschreibungspflichtige Arzneimittel) was lifted in 2004, but significant impetus for digitalization only emerged with the introduction of the electronic prescription (e-Rezept).

In Germany, the mandatory rollout of the e-Rezept began in 2024, following a phased introduction. This digital infrastructure is a critical enabler for the expansion of online Rx sales. While the initial adoption rates for the e-Rezept have been progressive, full market penetration is a multi-year process. By 2026, it is projected that approximately 60% of all prescriptions in Germany will be issued digitally, facilitating a substantial increase in online Rx fulfillment. The CAGR for online Rx sales in Germany from 2023 to 2026 is projected at 28.0%, significantly outpacing the OTC segment. This accelerated growth is a direct consequence of the e-Rezept implementation creating new digital pathways for prescription fulfillment.

In Austria and Switzerland, regulatory frameworks for online Rx sales are more restrictive compared to Germany. Austria generally permits online sales of certain Rx medications under strict conditions, often requiring a doctor’s consultation or existing patient relationship with a local pharmacy. Switzerland allows online sales of specific Rx drugs, but the market volume remains comparatively low due to stringent regulations and the strong presence of local pharmacies. Consequently, the contribution of online Rx sales from Austria and Switzerland to the overall DACH digital pharmacy market remains marginal compared to Germany.

Leading Digital Pharmacy Players and Market Concentration

The DACH digital pharmacy market exhibits a notable degree of concentration among a few key players, particularly within the German market, which dominates the regional landscape.

Redcare Pharmacy N.V. (formerly Zur Rose Group AG), operating primarily through its DocMorris brand in Germany and the Netherlands, and Shop Apotheke Europe N.V. are the two largest pure-play online pharmacies in the DACH region. These entities have invested significantly in logistical infrastructure, digital platforms, and marketing, establishing substantial market shares.

In 2023, Redcare Pharmacy and Shop Apotheke Europe collectively accounted for approximately 70% of the online pharmacy market revenue in Germany. This concentration reflects economies of scale, extensive product ranges, and established brand recognition. Other players include smaller independent online pharmacies and the growing online presence of traditional brick-and-mortar pharmacy chains (Apothekenketten) that offer click-and-collect services or local delivery options.

The introduction of the e-Rezept in Germany has intensified competition, as traditional pharmacies are also adapting their digital services to process electronic prescriptions. However, the established pure-play online pharmacies possess a significant operational advantage in handling large volumes of digital orders and managing complex logistics for direct-to-consumer delivery.

Consumer Adoption and Digital Penetration

Consumer adoption of digital pharmacy services in the DACH region is steadily increasing, driven by convenience, product availability, and, more recently, the digitalization of the prescription process.

In 2023, approximately 28% of the adult population in Germany reported purchasing pharmacy products online at least once within the preceding 12 months. This figure is projected to reach 35% by 2026. For Austria and Switzerland, consumer penetration rates are slightly lower, estimated at 22% and 20% respectively in 2023, with similar growth trends anticipated.

Mobile devices are increasingly becoming the primary channel for accessing digital pharmacy platforms. In 2023, mobile commerce (purchases via smartphones or tablets) accounted for 55% of all digital pharmacy transactions in Germany, up from 48% in 2021. This trend underscores the importance of mobile-optimized user experiences and applications for digital pharmacy providers. Desktop usage, while still significant, is experiencing a relative decline in transaction share.

The primary drivers for online pharmacy usage cited by consumers include:

• Convenience: 24/7 accessibility and home delivery.
• Price: Perceived cost advantages for non-prescription items.
• Product Range: Access to a broader assortment of health and wellness products not always available in local pharmacies.
• Anonymity: For certain health conditions or products.

Regulatory Environment and its Impact on Digital Growth

The regulatory landscape is a determining factor for the scope and growth of digital pharmacy retail in the DACH region.

Germany

The e-Rezept (electronic prescription) is the most significant regulatory development influencing the German digital pharmacy market. Its nationwide mandatory introduction in 2024 fundamentally altered the process of prescription fulfillment. Prior to this, paper prescriptions were the standard, limiting the digital processing of Rx medications. The e-Rezept system, managed by gematik GmbH, enables doctors to issue prescriptions digitally, which patients can then redeem via an app (e.g., e-Rezept-App der gematik) or a paper token (Tokenausdruck) at any pharmacy, including Versandapotheken. This digital infrastructure facilitates a seamless ordering process for online pharmacies, directly impacting their potential for Rx market share growth.

Furthermore, German law distinguishes between “Apotheken mit Präsenzpflicht” (brick-and-mortar pharmacies with physical presence) and “Versandapotheken” (mail-order pharmacies). All Versandapotheken, whether domestic or foreign EU-based, must comply with German pharmaceutical law, including requirements for quality assurance, patient counseling, and data protection. The legal framework ensures that online pharmacies adhere to comparable standards as traditional pharmacies, fostering consumer trust while regulating market access.

Austria

In Austria, the online sale of prescription-only medicines is generally restricted. The Apothekengesetz (Pharmacy Act) primarily emphasizes the role of local pharmacies for dispensing Rx medications. While some exceptions exist for specific online services linked to physical pharmacies, a broad mail-order market for Rx drugs comparable to Germany’s is not present. For OTC products, online sales are more prevalent, subject to regulations concerning product information and quality.

Switzerland

Switzerland operates under a canton-based regulatory system, leading to variations in pharmacy laws. The Heilmittelgesetz (HMG) and related ordinances govern the dispensing of medicines. Online sales of prescription drugs are permitted under specific conditions, often requiring a license and adherence to stringent safety and quality standards, including professional advice. However, the market for online Rx sales remains limited, with a strong emphasis on the role of local pharmacies and direct patient contact. The digital retail of OTC products is more established but also subject to regulatory oversight.

The varying regulatory approaches across the DACH countries create a fragmented but evolving digital pharmacy landscape, with Germany spearheading the digitalization of prescription fulfillment.

Frequently Asked Questions

What is the projected market value for DACH digital pharmacy retail in 2026? The aggregated digital pharmacy retail market in the DACH region is projected to reach €9.5 billion by 2026. This represents a Compound Annual Growth Rate (CAGR) of 11.5% from its 2023 value of €6.8 billion.

What percentage of the total DACH pharmacy market is expected to be online by 2026? The online share of the total pharmacy market in the DACH region is projected to expand to 11.5% by 2026. This is an increase from approximately 8.2% in 2023, indicating a gradual shift towards digital channels.

What is the projected growth rate for online prescription (Rx) sales in Germany from 2023 to 2026? Online Rx sales in Germany are projected to grow at a Compound Annual Growth Rate (CAGR) of 28.0% from 2023 to 2026. This accelerated growth is primarily driven by the mandatory implementation of the e-Rezept.

Which companies dominate the DACH digital pharmacy retail market? Redcare Pharmacy N.V. (operating primarily through DocMorris) and Shop Apotheke Europe N.V. are the two largest pure-play online pharmacies in the DACH region. In 2023, these entities collectively accounted for approximately 70% of the online pharmacy market revenue in Germany.

What is the anticipated e-Rezept penetration in Germany by 2026? By 2026, it is projected that approximately 60% of all prescriptions in Germany will be issued digitally. This widespread adoption of the e-Rezept is a critical enabler for the expansion of online Rx sales.

For deeper strategic analysis, see our full report.

The DACH digital pharmacy market is projected to reach €9.5 billion by 2026, representing an 11.5% online share of the total pharmacy market. This expansion is significantly driven by Germany’s e-Rezept implementation, which is set to boost online Rx sales in the country by a 28.0% CAGR. The regional landscape remains characterized by evolving regulatory frameworks and concentrated market leadership.